Endogenous TRPV1 agonist OLDA prevents mu-opioid receptor desensitization and preserves analgesia in sensitized

Related Experiment Video

Updated: Apr 18, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

9.1K

Mario Heles1, Daniel Vasconcelos1, Jiri Palecek1

  • 1Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

Neuropharmacology
|April 16, 2026
PubMed

Insights

N-oleoyldopamine (OLDA), an endogenous vanilloid, preserves opioid analgesia by preventing μ-opioid receptor (MOR) desensitization. This discovery offers a new way to improve opioid pain relief, especially in chronic pain conditions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Opioid analgesics, primarily acting via the μ-opioid receptor (MOR), face limitations due to receptor desensitization, tolerance, and opioid-induced hyperalgesia.
  • Functional crosstalk between MOR and the transient receptor potential vanilloid 1 (TRPV1) channel suggests TRPV1 activation can mitigate MOR desensitization.
  • The role of endogenous TRPV1 ligands in regulating MOR signaling within intact nociceptive circuits remained unclear.

Purpose of the Study:

  • To investigate whether endogenous TRPV1 ligands modulate MOR desensitization in nociceptive circuits.
  • To determine if N-oleoyldopamine (OLDA) preserves MOR signaling and opioid analgesia.
  • To explore the therapeutic potential of OLDA in enhancing opioid efficacy and safety.

Main Methods:

  • Electrophysiological recordings from rat spinal cord dorsal horn neurons.
  • Assessment of MOR agonist DAMGO-induced desensitization with and without OLDA co-incubation.
  • Evaluation of OLDA's efficacy in neuropathic pain models (chronic constriction injury) and chemokine-induced MOR desensitization models.
  • In vivo assessment of OLDA's effect on opioid-evoked hypoalgesia.

Main Results:

  • Prolonged MOR agonist exposure induced significant desensitization, abolishing opioid-mediated inhibition.
  • Co-incubation with OLDA prevented MOR desensitization in a concentration-dependent manner, maintaining opioid efficacy.
  • Under neuropathic conditions, lower OLDA concentrations preserved MOR responsiveness, suggesting enhanced TRPV1 sensitization.
  • Intrathecal OLDA administration restored opioid-evoked hypoalgesia in a MOR desensitization model.

Conclusions:

  • N-oleoyldopamine (OLDA) acts as an endogenous regulator of TRPV1-MOR crosstalk, preserving MOR signaling and opioid analgesia.
  • OLDA selectively maintains opioid signaling in sensitized nociceptive circuits, particularly under neuropathic pain conditions.
  • These findings reveal an intrinsic modulatory system that could be leveraged to enhance the durability and safety of opioid analgesia, offering a promising avenue for chronic pain management.
Keywords:
N-oleoyldopamine (OLDA)Neuropathic painOpioid analgesiaOpioid desensitizationTRPV1β-arrestin

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.4K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 109:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
35.0K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.0K